PANAGORA ASSET MANAGEMENT INC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 62 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$83,000
-10.8%
2,192
-60.0%
0.00%
-100.0%
Q4 2020$93,000
-89.8%
5,474
-97.2%
0.00%
-83.3%
Q3 2020$913,000
+62.5%
194,225
+110.8%
0.01%
+50.0%
Q2 2020$562,000
+11140.0%
92,127
+4118.3%
0.00%
Q1 2020$5,000
-50.0%
2,1840.0%0.00%
Q4 2019$10,000
-99.2%
2,184
-99.3%
0.00%
-100.0%
Q3 2019$1,229,000
+10.8%
317,224
+72.5%
0.01%
+20.0%
Q2 2019$1,109,000
+499.5%
183,933
+1229.5%
0.01%
+400.0%
Q1 2019$185,000
-13.6%
13,835
+2.4%
0.00%0.0%
Q2 2018$214,000
-80.1%
13,515
-78.4%
0.00%
-75.0%
Q1 2018$1,073,000
+1147.7%
62,431
+2082.1%
0.00%
Q2 2017$86,000
-16.5%
2,8610.0%0.00%
Q1 2017$103,000
-82.5%
2,861
-75.7%
0.00%
-100.0%
Q4 2016$590,000
+143.8%
11,782
+155.9%
0.00%
+200.0%
Q3 2016$242,000
+1916.7%
4,604
+1504.2%
0.00%
Q1 2016$12,000
-85.9%
287
-85.9%
0.00%
Q4 2015$85,000
+304.8%
2,040
+51.4%
0.00%
Q3 2015$21,000
-48.8%
1,347
-49.3%
0.00%
Q2 2014$41,000
-92.8%
2,655
-90.8%
0.00%
-100.0%
Q1 2014$567,000
-37.6%
28,861
-46.6%
0.00%
-25.0%
Q4 2013$908,00054,0790.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
BVF INC/IL 6,338,678$238,778,0008.95%
One Fin Capital Management LP 440,000$16,575,0006.37%
COMMODORE CAPITAL LP 361,344$13,612,0005.42%
Chicago Capital Management, LLC 295,864$11,145,0005.19%
Kellner Capital, LLC 226,876$8,546,0003.10%
HARVEST MANAGEMENT LLC 97,500$3,673,0002.20%
Rock Springs Capital Management LP 2,660,822$100,233,0002.19%
ALPINE ASSOCIATES MANAGEMENT INC. 2,007,700$75,630,0002.05%
NEXPOINT ASSET MANAGEMENT, L.P. 198,278$7,469,0001.95%
GARDNER LEWIS ASSET MANAGEMENT L P 236,565$8,911,0001.60%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders